Pediatrics

In a new clinical trial, Stanford Medicine researchers found that a commonly used anti-nausea drug could reduce the severity of opioid withdrawal in newborns.

Research into medical decisions for children with terminal illnesses can be improved by sensitively tapping the expertise of families who have lost a child, according to Stanford Medicine experts.

About 80% of children with autism have trouble sleeping, but whether better sleep could lessen other autism symptoms is unknown. A new grant will help Stanford Medicine scientists find out.

Nearly half of parents with a child who received an implantable device to correct abnormal heart rhythms met criteria for post-traumatic stress disorder, a Stanford Medicine-led study found.

Diabetes treatment technology improved teenagers’ blood sugar levels and benefited their brain structure and function, according to a study led by Stanford Medicine researchers.

Santa Clara County recognized Stanford’s pediatric emergency department for its ability to handle a broad spectrum of medical emergencies in young patients.

Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.

Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.

The funding, from Cancer Grand Challenges, will help the researchers address difficult problems in cancer prevention, treatment-resistant cancers and therapies for pediatric solid tumors.

Stanford Medicine researchers and colleagues found that as nations industrialize, a species of bacteria critical in the early development of infant gut microbiomes fades away.

Stanford researchers modified anti-cancer CAR-T cells so they can be controlled with an oral drug. The modified cells are safer, more potent and more active against solid tumors in mice.